These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 6460555
1. Comparative effects of methotrexate, two nonclassic folic acid antagonists, and cytarabine on hematopoietic precursor cells. Marsh JC. Cancer Treat Rep; 1982 Mar; 66(3):499-504. PubMed ID: 6460555 [Abstract] [Full Text] [Related]
2. Leucovorin antagonizes the effects of trimetrexate on mouse hemopoietic progenitors. Lerza R, Mencoboni M, Bogliolo G, Flego G, Gasparini L, Pannacciulli I. Anticancer Res; 1991 Mar; 11(2):613-6. PubMed ID: 1829599 [Abstract] [Full Text] [Related]
3. Toxicity of trimetrexate on hemopoietic progenitor cells in normal mice. Bogliolo GV, Lerza RA, Mencoboni MP, Saviane AG, Pannacciulli IM. Anticancer Res; 1988 Mar; 8(2):229-31. PubMed ID: 2966606 [Abstract] [Full Text] [Related]
4. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells. Bowen D, Southerland WM, Johnson DH, Hawkins M, Hughes DE. Cancer Detect Prev; 2000 Mar; 24(5):452-8. PubMed ID: 11129987 [Abstract] [Full Text] [Related]
5. Inhibition of DNA synthesis in normal and malignant human cells by triazinate (Baker's antifol) and methotrexate. Skeel RT, Sawicki WL, Cashmore AR, Bertino JR. Cancer Res; 1976 Oct; 36(10):3659-64. PubMed ID: 953990 [Abstract] [Full Text] [Related]
6. Comparison of the sensitivities of human, canine, and murine hematopoietic precursor cells to adriamycin and N-trifluoroacetyladriamycin-14-valerate. Marsh JC. Cancer Res; 1979 Feb; 39(2 Pt 1):360-4. PubMed ID: 761207 [Abstract] [Full Text] [Related]
7. Suppression of B cell function by methotrexate and trimetrexate. Evidence for inhibition of purine biosynthesis as a major mechanism of action. Rosenthal GJ, Weigand GW, Germolec DR, Blank JA, Luster MI. J Immunol; 1988 Jul 15; 141(2):410-6. PubMed ID: 2968399 [Abstract] [Full Text] [Related]
8. Correlation of hematologic toxicity of antineoplastic agents with their effects on bone marrow stem cells: interspecies studies using an in vivo assay. Marsh JC. Exp Hematol; 1985 Jul 15; 13 Suppl 16():16-22. PubMed ID: 3987835 [Abstract] [Full Text] [Related]
9. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy]. Lu P, Lu Y, Pang K, Wang SB, Chen JQ, Xu HM, Wang JK, Zhao SC. Zhonghua Wai Ke Za Zhi; 2005 Aug 01; 43(15):998-1001. PubMed ID: 16194358 [Abstract] [Full Text] [Related]
10. Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum. Sobrero AF, Bertino JR. Int J Cell Cloning; 1986 Jan 01; 4(1):51-62. PubMed ID: 2936838 [Abstract] [Full Text] [Related]
11. A comparison of the effects of nine folate analogs on early and late murine hematopoietic progenitor cells in vitro. Strømhaug A, Warren DJ. Cancer Chemother Pharmacol; 2000 Jan 01; 45(6):450-6. PubMed ID: 10854131 [Abstract] [Full Text] [Related]
12. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity. Belur LR, James RI, May C, Diers MD, Swanson D, Gunther R, McIvor RS. J Pharmacol Exp Ther; 2005 Aug 01; 314(2):668-74. PubMed ID: 15857949 [Abstract] [Full Text] [Related]
13. Incidence and characteristics of colony-forming units fibroblasts (CFU-F) in the bone marrow of weanling mice treated with cytosine arabinoside and phenylhydrazine: correlation with CFU-S, progenitors of diffusion-chamber colonies (CFU-D), and CFU-C. Ben-Ishay Z, Borenstein A, Sharon S, Prindull G. Int J Cell Cloning; 1983 Oct 01; 1(5):343-59. PubMed ID: 6672102 [Abstract] [Full Text] [Related]
14. The sensitivities of human and murine hemopoietic cells exposed to cytotoxic drugs in an in vivo culture system. Gordon MY, Blackett N. Cancer Res; 1976 Aug 01; 36(8):2822-6. PubMed ID: 1277192 [Abstract] [Full Text] [Related]
15. Combined effect of cytosine arabinoside and thiopurines. Valeriote F, Vietti T, Edelstein M. Cancer Treat Rep; 1976 Dec 01; 60(12):1925-34. PubMed ID: 1026347 [Abstract] [Full Text] [Related]
16. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells. Rhee MS, Galivan J, Wright JE, Rosowsky A. Mol Pharmacol; 1994 Apr 01; 45(4):783-91. PubMed ID: 7514264 [Abstract] [Full Text] [Related]
17. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate. James RI, May C, Vagt MD, Studebaker R, McIvor RS. Exp Hematol; 1997 Nov 01; 25(12):1286-95. PubMed ID: 9357973 [Abstract] [Full Text] [Related]
18. Sensitivity of bone marrow hematopoietic colony-forming cells from mice, dogs, and humans to carminomycin, marcellomycin, aclacinomycin A, and N,N-dibenzyldaunorubicin and its relationship to clinical toxicity. Marsh JC, Brown BJ, Nierenburg MM. Cancer Res; 1983 Jun 01; 43(6):2962-6. PubMed ID: 6573955 [Abstract] [Full Text] [Related]
19. Effects of methotrexate and of the "nonclassical" folate antagonist trimetrexate on human leukemia cells. Rodenhuis S, McGuire JJ, Sawicki WL, Bertino JR. Leukemia; 1987 Feb 01; 1(2):116-20. PubMed ID: 2959824 [Abstract] [Full Text] [Related]
20. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells. Chen G, Wright JE, Rosowsky A. Mol Pharmacol; 1995 Oct 01; 48(4):758-65. PubMed ID: 7476904 [Abstract] [Full Text] [Related] Page: [Next] [New Search]